We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · December 12, 2019

High-Dose EPA in the Treatment of ADHD

Translational Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

Translational Psychiatry
High-Dose Eicosapentaenoic Acid (EPA) Improves Attention and Vigilance in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) and Low Endogenous EPA Levels
Transl Psychiatry 2019 Nov 20;9(1)303, JP Chang, KP Su, V Mondelli, SK Satyanarayanan, HT Yang, YJ Chiang, HT Chen, CM Pariante

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading